Application | Comment | Organism |
---|---|---|
drug development | mtDHFR is an attractive target for the development of anti-tuberculosis drugs | Mycobacterium tuberculosis |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
L-tryptophyl-L-tyrosyl-L-tyrosine | development of a tri-peptide inhibitor using a structure-based drug design approach, docking studies and molecular dynamics, overview | Mycobacterium tuberculosis | |
methotrexate | - |
Mycobacterium tuberculosis | |
pyrimethamine | - |
Mycobacterium tuberculosis | |
trimethoprim | weak inhibition | Mycobacterium tuberculosis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
7,8-dihydrofolate + NADPH + H+ | Mycobacterium tuberculosis | the reaction is essential in DNA synthesis | 5,6,7,8-tetrahydrofolate + NADP+ | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
7,8-dihydrofolate + NADPH + H+ | - |
Mycobacterium tuberculosis | 5,6,7,8-tetrahydrofolate + NADP+ | - |
? | |
7,8-dihydrofolate + NADPH + H+ | the reaction is essential in DNA synthesis | Mycobacterium tuberculosis | 5,6,7,8-tetrahydrofolate + NADP+ | - |
? |
Synonyms | Comment | Organism |
---|---|---|
DHFR | - |
Mycobacterium tuberculosis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADPH | - |
Mycobacterium tuberculosis |
General Information | Comment | Organism |
---|---|---|
malfunction | inhibition of the enzyme activity leads to arrest of DNA synthesis and hence cell death | Mycobacterium tuberculosis |
physiological function | tetrahydrofolate is a precursor of cofactors necessary for the synthesis of thymidylate, purine nucleotides,methionine, serine, and glycine required for DNA, RNA, and protein synthesis | Mycobacterium tuberculosis |